179 related articles for article (PubMed ID: 14522891)
1. High-throughput molecular analysis of urine sediment for the detection of bladder cancer by high-density single-nucleotide polymorphism array.
Hoque MO; Lee J; Begum S; Yamashita K; Engles JM; Schoenberg M; Westra WH; Sidransky D
Cancer Res; 2003 Sep; 63(18):5723-6. PubMed ID: 14522891
[TBL] [Abstract][Full Text] [Related]
2. Genomic instability analysis of urine sediment versus tumor tissue in transitional cell carcinoma of the urinary bladder.
Turyn J; Matuszewski M; Schlichtholz B
Oncol Rep; 2006 Jan; 15(1):259-65. PubMed ID: 16328066
[TBL] [Abstract][Full Text] [Related]
3. Microsatellite analysis of urine sediment versus urine cytology for diagnosing transitional cell tumors of the urinary bladder.
Fornari D; Steven K; Hansen AB; Vibits H; Jepsen JV; Poulsen AL; Schwartz M; Horn T
APMIS; 2004 Feb; 112(2):148-52. PubMed ID: 15056232
[TBL] [Abstract][Full Text] [Related]
4. Allelic deletion fingerprinting of urine cell sediments in bladder cancer.
Larsson PC; Beheshti B; Sampson HA; Jewett MA; Shipman R
Mol Diagn; 2001 Sep; 6(3):181-8. PubMed ID: 11571711
[TBL] [Abstract][Full Text] [Related]
5. Allelic imbalance analysis using a single-nucleotide polymorphism microarray for the detection of bladder cancer recurrence.
Coenen MJ; Ploeg M; Schijvenaars MM; Cornel EB; Karthaus HF; Scheffer H; Witjes JA; Franke B; Kiemeney LA
Clin Cancer Res; 2008 Dec; 14(24):8198-204. PubMed ID: 19088036
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer.
Schneider A; Borgnat S; Lang H; Régine O; Lindner V; Kassem M; Saussine C; Oudet P; Jacqmin D; Gaub MP
Cancer Res; 2000 Aug; 60(16):4617-22. PubMed ID: 10969815
[TBL] [Abstract][Full Text] [Related]
7. Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer.
Friedrich MG; Erbersdobler A; Schwaibold H; Conrad S; Huland E; Huland H
J Urol; 2000 Mar; 163(3):1039-42. PubMed ID: 10688045
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradient gel electrophoresis urinalysis.
Curigliano G; Ferretti G; Flamini G; Goldhirsch A; de Braud F; Calabro MG; Mandaly M; Nole F; De Pas T; D'Addessi A; Cittadini A
Anticancer Res; 2001; 21(4B):3015-20. PubMed ID: 11712804
[TBL] [Abstract][Full Text] [Related]
9. [Microsatellite instability in urine sediments from patients with transitional cell carcinoma of bladder and its clinical value].
Lü Y; Tang D; Yu L; Ding Y; Liu L; Guo Y
Zhonghua Wai Ke Za Zhi; 2000 Apr; 38(4):294-6. PubMed ID: 12828175
[TBL] [Abstract][Full Text] [Related]
10. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
Dahse R; Utting M; Werner W; Schimmel B; Claussen U; Junker K
Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
[TBL] [Abstract][Full Text] [Related]
11. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
[TBL] [Abstract][Full Text] [Related]
12. Molecular urinary sediment analysis in patients with transitional cell bladder carcinoma.
Dal Canto M; Bartoletti R; Travaglini F; Piazzini M; Lodovichi G; Rizzo M; Selli C
Anticancer Res; 2003; 23(6D):5095-100. PubMed ID: 14981972
[TBL] [Abstract][Full Text] [Related]
13. [The diagnostic value of microsatellite LOH analysis and the prognostic relevance of angiogenic gene expression in urinary bladder cancer].
Szarvas T
Magy Onkol; 2009 Dec; 53(4):385-9. PubMed ID: 20071311
[TBL] [Abstract][Full Text] [Related]
14. Detection of bladder cancer by semi-automated microsatellite analysis of urine sediment.
Baron A; Mastroeni F; Moore PS; Bonetti F; Orlandini S; Manfrin E; Schiavone D; Migliorini F; Lusuardi L; Mobilio G; Scarpa A
Adv Clin Path; 2000 Jan; 4(1):19-24. PubMed ID: 10936895
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer trial [CEFUB]).
van der Aa MN; Zwarthoff EC; Steyerberg EW; Boogaard MW; Nijsen Y; van der Keur KA; van Exsel AJ; Kirkels WJ; Bangma C; van der Kwast TH
Eur Urol; 2009 Mar; 55(3):659-67. PubMed ID: 18501499
[TBL] [Abstract][Full Text] [Related]
16. Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment.
Szarvas T; Kovalszky I; Bedi K; Szendroi A; Majoros A; Riesz P; Füle T; László V; Kiss A; Romics I
Oncol Rep; 2007 Aug; 18(2):405-9. PubMed ID: 17611663
[TBL] [Abstract][Full Text] [Related]
17. Transitional cell bladder tumor: predicting recurrence and progression by analysis of microsatellite loss of heterozygosity in urine sediment and tumor tissue.
Fornari D; Steven K; Hansen AB; Jepsen JV; Poulsen AL; Vibits H; Horn T
Cancer Genet Cytogenet; 2006 May; 167(1):15-9. PubMed ID: 16682280
[TBL] [Abstract][Full Text] [Related]
18. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.
Hautmann S; Toma M; Lorenzo Gomez MF; Friedrich MG; Jaekel T; Michl U; Schroeder GL; Huland H; Juenemann KP; Lokeshwar VB
Eur Urol; 2004 Oct; 46(4):466-71. PubMed ID: 15363562
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis.
Rouprêt M; Hupertan V; Yates DR; Comperat E; Catto JW; Meuth M; Lackmichi A; Ricci S; Lacave R; Gattegno B; Richard F; Hamdy FC; Cussenot O
BJU Int; 2008 Jun; 101(11):1448-53. PubMed ID: 18325051
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
